Identification of the regulatory region required for ubiquitination of the cyclin kinase inhibitor, p21
- 26 April 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 293 (1), 120-125
- https://doi.org/10.1016/s0006-291x(02)00198-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathwayOncogene, 1999
- Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNACell, 1996
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Production and characterization of monoclonal antibodies specific to multi‐ubiquitin chains of polyubiquitinated proteinsFEBS Letters, 1994
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993